I
REGN icon

InceptionR’s Regeneron Pharmaceuticals REGN Stock Holding History

InceptionR’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$787K Buy
1,262
+375
+42% +$255K 0.19% 198
2026
Q1 		$685K Buy
+887
New +$679K 0.17% 213
2025
Q4 		– Sell
-390
Closed -$219K – 830
2025
Q3 		$219K Sell
390
-234
-38% -$132K 0.05% 580
2025
Q2 		$328K Buy
+624
New +$348K 0.08% 428
2024
Q2 		– Sell
-1,792
Closed -$1.72M – 810
2024
Q1 		$1.72M Buy
1,792
+1,244
+227% +$1.18M 0.44% 22
2023
Q4 		$481K Buy
+548
New +$451K 0.34% 112
2023
Q2 		– Sell
-263
Closed -$216K – 589
2023
Q1 		$216K Buy
+263
New +$198K 0.07% 385

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

InceptionR's REGN Position: Q2 2026 in Review

InceptionR increased its Regeneron Pharmaceuticals (REGN) stake by 42% in Q2 2026, buying an estimated $255K and bringing the position to 1,262 shares worth $787K. The position accounts for 0.19% of the portfolio, ranked #198.

InceptionR first reported a position in REGN in Q1 2023 and has held it in 7 quarters since. The position peaked at $1.72M in Q1 2024. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • InceptionR held 1,262 shares of Regeneron Pharmaceuticals worth $787K as of Q2 2026.
  • InceptionR bought 375 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $255K.
  • Regeneron Pharmaceuticals made up 0.19% of InceptionR's portfolio in Q2 2026, its #198 holding.
  • InceptionR first reported a position in Regeneron Pharmaceuticals in Q1 2023 and has held it in 7 quarters since.
  • InceptionR's Regeneron Pharmaceuticals position peaked at $1.72M in Q1 2024.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.